How to Buy blissgvs Shares on Fincept?
You can buy Bliss GVS Pharma Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Bliss GVS Pharma Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Blissgvs, including updates on board meetings and corporate actions.
Bliss GVS Pharma Limited - https://www.blissgvs.com
Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.
Bliss GVS Pharma Limited Share Price Today
146.01
OPEN
158.50
HIGH
146.01
LOW
156.40
CLOSE
1,315 K
VOLUME
1,680 Cr
Market Cap
1414157
Average Volume
Healthcare
Sector
NSI
Exchange
Bliss GVS Pharma Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: BLISSGVS Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Bliss GVS Pharma Limited |
BLISSGVS |
INE416D01022 |
Annual General Meeting/Dividend - Rs 0.50 Per Share |
18 Jul 2024 |
1 |
N/A |
Bliss GVS Pharma Limited |
BLISSGVS |
INE416D01022 |
Annual General Meeting/Dividend - Re 0.50 Per Share |
12 Jul 2023 |
1 |
N/A |
Bliss GVS Pharma Limited |
BLISSGVS |
INE416D01022 |
Annual General Meeting/ Dividend - Rs 0.50 Per Share |
20 Jun 2022 |
1 |
N/A |
Bliss GVS Pharma Limited |
BLISSGVS |
INE416D01022 |
Annual General Meeting/Dividend - Rs 0.50 Per Share |
13 Sep 2021 |
1 |
N/A |
Bliss GVS Pharma Limited |
BLISSGVS |
INE416D01022 |
Annual General Meeting/Dividend - Rs 0.50 Per Share |
17 Sep 2020 |
1 |
N/A |
NSE: BLISSGVS Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
BLISSGVS |
02 Jan 2025, 17:11:56 |
Updates |
Pharmaceuticals |
BLISSGVS |
31 Dec 2024, 12:46:46 |
Trading Window-XBRL |
Pharmaceuticals |
BLISSGVS |
31 Dec 2024, 12:45:36 |
Trading Window |
Pharmaceuticals |
BLISSGVS |
06 Dec 2024, 18:45:52 |
Alteration Of Capital and Fund Raising-XBRL |
Pharmaceuticals |
BLISSGVS |
06 Dec 2024, 18:43:44 |
Updates |
Pharmaceuticals |
NSE: BLISSGVS Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Bliss GVS Pharma Limited |
BLISSGVS |
21 Oct 2024, 20:23:00 |
21 Oct 2024, 20:24:00 |
|
Bliss GVS Pharma Limited |
BLISSGVS |
28 Aug 2024, 12:25:00 |
28 Aug 2024, 12:25:00 |
|
Bliss GVS Pharma Limited |
BLISSGVS |
17 Apr 2024, 16:18:00 |
17 Apr 2024, 16:45:00 |
|
Bliss GVS Pharma Limited |
BLISSGVS |
20 Jan 2024, 16:45:00 |
20 Jan 2024, 17:15:00 |
|
Bliss GVS Pharma Limited |
BLISSGVS |
21 Oct 2023, 16:45:00 |
21 Oct 2023, 17:15:00 |
NSE: BLISSGVS Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Independent Director,Chairperson & Non-Executive Director |
26 Oct 1942 |
01 Aug 2011 |
03600249 |
Subramanian Ramaswamy Vaidya |
Active |
Independent Director |
19 Aug 1970 |
24 May 2016 |
01622988 |
Santosh Laxman Parab |
Active |
Independent Director |
28 May 1949 |
22 Jun 2024 |
02736718 |
Nandkumar Kashinath Chodankar |
Active |
Executive Director-MD |
10 Aug 1982 |
21 Jan 2021 |
07939421 |
Gagan Harsh Sharma |
Active |
Independent Director |
29 Mar 1974 |
11 Feb 2020 |
08695595 |
Shilpa Vinodkumar Bhatia |
Active |
NSE: BLISSGVS Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
BLISS GVS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 24-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 . |
BLISSGVS |
N/A |
INE416D01022 |
Bliss GVS Pharma Limited |
17 Oct 2024, 19:30:47 |
BLISS GVS PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 24-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
BLISSGVS |
N/A |
INE416D01022 |
Bliss GVS Pharma Limited |
17 Jul 2024, 15:07:16 |
Financial Results/Dividend/Other business matters |
BLISSGVS |
N/A |
INE416D01022 |
Bliss GVS Pharma Limited |
25 Apr 2024, 22:06:02 |
Financial Results/Other business matters |
BLISSGVS |
N/A |
INE416D01022 |
Bliss GVS Pharma Limited |
16 Jan 2024, 18:27:09 |
Financial Results/Other business matters |
BLISSGVS |
N/A |
INE416D01022 |
Bliss GVS Pharma Limited |
25 Oct 2023, 21:39:02 |
NSE: BLISSGVS Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results/Other business matters |
BLISSGVS |
- |
INE416D01022 |
Bliss GVS Pharma Limited |
17 Oct 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financial Results/Other business matters |
BLISSGVS |
- |
INE416D01022 |
Bliss GVS Pharma Limited |
17 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Financial Results/Dividend/Other business matters |
BLISSGVS |
- |
INE416D01022 |
Bliss GVS Pharma Limited |
25 Apr 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024, dividend and other business matters |
Financial Results/Other business matters |
BLISSGVS |
- |
INE416D01022 |
Bliss GVS Pharma Limited |
16 Jan 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results/Other business matters |
BLISSGVS |
- |
INE416D01022 |
Bliss GVS Pharma Limited |
25 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
NSE: BLISSGVS Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Other Investments | Investmentin Financial Assets | Held To Maturity Securities | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Long Term Equity Investment | Investmentsin Subsidiariesat Cost | Investment Properties | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Inventories Adjustments Allowances | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 105,144,472.00 | 105,144,472.00 | 501,783,000.00 | 941,724,000.00 | 10,019,629,000.00 | 10,932,341,000.00 | 6,588,274,000.00 | 10,019,629,000.00 | 108,842,000.00 | 10,099,459,000.00 | 10,384,421,000.00 | 10,480,413,000.00 | 380,954,000.00 | 10,099,459,000.00 | 9,994,315,000.00 | 0.00 | 0.00 | 105,144,000.00 | 105,144,000.00 | 2,344,646,000.00 | 418,788,000.00 | 538,000.00 | 0.00 | 0.00 | 19,579,000.00 | 364,929,000.00 | 79,967,000.00 | 284,962,000.00 | 33,742,000.00 | 1,925,858,000.00 | 59,091,000.00 | 576,795,000.00 | 28,875,000.00 | 547,920,000.00 | 0.00 | 7,632,000.00 | 982,023,000.00 | 0.00 | 0.00 | 24,478,000.00 | 957,545,000.00 | 12,825,059,000.00 | 4,310,927,000.00 | 235,022,000.00 | 0.00 | 0.00 | 0.00 | 197,398,000.00 | 0.00 | 197,398,000.00 | 0.00 | 0.00 | 0.00 | 6,837,000.00 | 79,830,000.00 | 2,719,000.00 | 77,111,000.00 | 3,791,840,000.00 | 0.00 | 3,791,840,000.00 | 236,210,000.00 | 3,555,630,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,514,132,000.00 | 556,885,000.00 | 0.00 | 0.00 | 1,314,051,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 487,000.00 | 29,178,000.00 | 4,283,217,000.00 | 0.00 | 0.00 | 2,330,314,000.00 | 1,999,215,000.00 | 331,099,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 104,690,822.00 | 104,690,822.00 | 646,666,000.00 | 998,401,000.00 | 9,593,755,000.00 | 10,550,000,000.00 | 6,517,981,000.00 | 9,593,755,000.00 | 120,334,000.00 | 9,671,933,000.00 | 10,027,855,000.00 | 10,029,833,000.00 | 357,900,000.00 | 9,671,933,000.00 | 77,249,000.00 | 8,869,901,000.00 | 331,644,000.00 | 104,691,000.00 | 104,691,000.00 | 2,108,851,000.00 | 510,641,000.00 | 606,000.00 | 25,394,000.00 | 606,000.00 | 35,932,000.00 | 448,709,000.00 | 92,787,000.00 | 355,922,000.00 | 25,394,000.00 | 1,598,210,000.00 | 6,606,000.00 | 549,692,000.00 | 27,547,000.00 | 522,145,000.00 | 0.00 | 0.00 | 972,574,000.00 | 336,496,000.00 | 6,977,000.00 | 19,448,000.00 | 609,653,000.00 | 12,138,684,000.00 | 4,022,493,000.00 | 126,626,000.00 | 126,626,000.00 | 0.00 | 0.00 | 117,055,000.00 | 0.00 | 81,023,000.00 | 36,032,000.00 | 0.00 | 0.00 | 6,845,000.00 | 78,178,000.00 | 1,067,000.00 | 77,111,000.00 | 3,693,789,000.00 | -967,867,000.00 | 4,661,656,000.00 | 78,270,000.00 | 3,615,519,000.00 | 2,616,236,000.00 | 1,557,275,000.00 | 409,875,000.00 | 0.00 | 8,116,191,000.00 | 587,310,000.00 | 758,055,000.00 | 587,310,000.00 | 1,184,473,000.00 | 0.00 | 164,993,000.00 | 402,897,000.00 | 62,994,000.00 | 553,589,000.00 | 105,562,000.00 | 29,148,000.00 | 4,043,467,000.00 | -362,108,000.00 | 4,405,575,000.00 | 1,408,176,000.00 | 1,176,775,000.00 | 231,401,000.00 | 56,182,000.00 | 175,219,000.00 |
| 2024-03-31T00:00:00 | annual | 104,690,822.00 | 104,690,822.00 | 646,666,000.00 | 998,401,000.00 | 9,593,755,000.00 | 10,550,000,000.00 | 6,517,981,000.00 | 9,593,755,000.00 | 120,334,000.00 | 9,671,933,000.00 | 10,027,855,000.00 | 10,029,833,000.00 | 357,900,000.00 | 9,671,933,000.00 | 77,249,000.00 | 8,869,901,000.00 | 331,644,000.00 | 104,691,000.00 | 104,691,000.00 | 2,108,851,000.00 | 510,641,000.00 | 606,000.00 | 25,394,000.00 | 606,000.00 | 35,932,000.00 | 448,709,000.00 | 92,787,000.00 | 355,922,000.00 | 25,394,000.00 | 1,598,210,000.00 | 6,606,000.00 | 549,692,000.00 | 27,547,000.00 | 522,145,000.00 | 0.00 | 0.00 | 972,574,000.00 | 336,496,000.00 | 6,977,000.00 | 19,448,000.00 | 609,653,000.00 | 12,138,684,000.00 | 4,022,493,000.00 | 126,626,000.00 | 126,626,000.00 | 0.00 | 0.00 | 117,055,000.00 | 0.00 | 81,023,000.00 | 36,032,000.00 | 0.00 | 0.00 | 6,845,000.00 | 78,178,000.00 | 1,067,000.00 | 77,111,000.00 | 3,693,789,000.00 | -967,867,000.00 | 4,661,656,000.00 | 78,270,000.00 | 3,615,519,000.00 | 2,616,236,000.00 | 1,557,275,000.00 | 409,875,000.00 | 0.00 | 8,116,191,000.00 | 587,310,000.00 | 758,055,000.00 | 587,310,000.00 | 1,184,473,000.00 | 0.00 | 164,993,000.00 | 402,897,000.00 | 62,994,000.00 | 553,589,000.00 | 105,562,000.00 | 29,148,000.00 | 4,043,467,000.00 | -362,108,000.00 | 4,405,575,000.00 | 1,408,176,000.00 | 1,176,775,000.00 | 231,401,000.00 | 56,182,000.00 | 175,219,000.00 |
| 2023-09-30T00:00:00 | quarterly | 104,398,672.00 | 104,398,672.00 | 440,259,000.00 | 995,534,000.00 | 9,221,383,000.00 | 10,162,205,000.00 | 5,742,381,000.00 | 9,221,383,000.00 | 133,471,000.00 | 9,300,142,000.00 | 9,764,740,000.00 | 9,627,869,000.00 | 327,727,000.00 | 9,300,142,000.00 | 9,195,743,000.00 | 0.00 | 0.00 | 104,399,000.00 | 104,399,000.00 | 2,343,299,000.00 | 620,480,000.00 | 673,000.00 | 0.00 | 0.00 | 29,662,000.00 | 571,125,000.00 | 106,527,000.00 | 464,598,000.00 | 19,020,000.00 | 1,722,819,000.00 | 118,293,000.00 | 424,409,000.00 | 26,944,000.00 | 397,465,000.00 | 0.00 | 34,405,000.00 | 908,535,000.00 | 0.00 | 0.00 | 31,573,000.00 | 876,962,000.00 | 11,971,168,000.00 | 4,505,968,000.00 | 142,145,000.00 | 0.00 | 0.00 | 0.00 | 550,252,000.00 | 0.00 | 550,252,000.00 | 0.00 | 0.00 | 0.00 | 6,853,000.00 | 78,759,000.00 | 1,648,000.00 | 77,111,000.00 | 3,727,959,000.00 | 0.00 | 3,727,959,000.00 | 18,191,000.00 | 3,709,768,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7,465,200,000.00 | 711,753,000.00 | 0.00 | 0.00 | 1,252,131,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 547,000.00 | 13,505,000.00 | 3,780,577,000.00 | 0.00 | 0.00 | 1,706,687,000.00 | 1,284,883,000.00 | 421,804,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 104,152,672.00 | 104,152,672.00 | 731,117,000.00 | 1,018,978,000.00 | 8,759,564,000.00 | 9,819,638,000.00 | 5,041,074,000.00 | 8,759,564,000.00 | 38,309,000.00 | 8,838,969,000.00 | 9,245,866,000.00 | 9,174,235,000.00 | 335,266,000.00 | 8,838,969,000.00 | 88,947,000.00 | 8,149,243,000.00 | 269,944,000.00 | 104,153,000.00 | 104,153,000.00 | 2,394,291,000.00 | 461,701,000.00 | 740,000.00 | 26,890,000.00 | 740,000.00 | 0.00 | 434,071,000.00 | 27,174,000.00 | 406,897,000.00 | 26,890,000.00 | 1,932,590,000.00 | 40,764,000.00 | 584,907,000.00 | 11,135,000.00 | 573,772,000.00 | 0.00 | 33,426,000.00 | 1,272,116,000.00 | 372,620,000.00 | 8,274,000.00 | 27,323,000.00 | 863,899,000.00 | 11,568,526,000.00 | 4,594,862,000.00 | 160,573,000.00 | 160,573,000.00 | 33,327,000.00 | 0.00 | 585,575,000.00 | 0.00 | 557,281,000.00 | 28,294,000.00 | 0.00 | 0.00 | 6,861,000.00 | 79,405,000.00 | 2,294,000.00 | 77,111,000.00 | 3,729,121,000.00 | -791,817,000.00 | 4,520,938,000.00 | 28,005,000.00 | 3,701,116,000.00 | 2,580,443,000.00 | 1,492,664,000.00 | 419,826,000.00 | 0.00 | 6,973,664,000.00 | 952,621,000.00 | 395,864,000.00 | 952,621,000.00 | 1,030,635,000.00 | 0.00 | 149,635,000.00 | 338,044,000.00 | 44,381,000.00 | 498,575,000.00 | 42,566,000.00 | 16,213,000.00 | 3,851,659,000.00 | -353,971,000.00 | 4,205,630,000.00 | 684,106,000.00 | 434,554,000.00 | 249,552,000.00 | 24,694,000.00 | 224,858,000.00 |
| 2023-03-31T00:00:00 | annual | 104,152,672.00 | 104,152,672.00 | 731,117,000.00 | 1,018,978,000.00 | 8,759,564,000.00 | 9,819,638,000.00 | 5,041,074,000.00 | 8,759,564,000.00 | 38,309,000.00 | 8,838,969,000.00 | 9,245,866,000.00 | 9,174,235,000.00 | 335,266,000.00 | 8,838,969,000.00 | 88,947,000.00 | 8,149,243,000.00 | 269,944,000.00 | 104,153,000.00 | 104,153,000.00 | 2,394,291,000.00 | 461,701,000.00 | 740,000.00 | 26,890,000.00 | 740,000.00 | 0.00 | 434,071,000.00 | 27,174,000.00 | 406,897,000.00 | 26,890,000.00 | 1,932,590,000.00 | 40,764,000.00 | 584,907,000.00 | 11,135,000.00 | 573,772,000.00 | 0.00 | 33,426,000.00 | 1,272,116,000.00 | 372,620,000.00 | 8,274,000.00 | 27,323,000.00 | 863,899,000.00 | 11,568,526,000.00 | 4,594,862,000.00 | 160,573,000.00 | 160,573,000.00 | 33,327,000.00 | 0.00 | 585,575,000.00 | 0.00 | 557,281,000.00 | 28,294,000.00 | 0.00 | 0.00 | 6,861,000.00 | 79,405,000.00 | 2,294,000.00 | 77,111,000.00 | 3,729,121,000.00 | -791,817,000.00 | 4,520,938,000.00 | 28,005,000.00 | 3,701,116,000.00 | 2,580,443,000.00 | 1,492,664,000.00 | 419,826,000.00 | 0.00 | 6,973,664,000.00 | 952,621,000.00 | 395,864,000.00 | 952,621,000.00 | 1,030,635,000.00 | 0.00 | 149,635,000.00 | 338,044,000.00 | 44,381,000.00 | 498,575,000.00 | 42,566,000.00 | 16,213,000.00 | 3,851,659,000.00 | -353,971,000.00 | 4,205,630,000.00 | 684,106,000.00 | 434,554,000.00 | 249,552,000.00 | 24,694,000.00 | 224,858,000.00 |
| 2022-03-31T00:00:00 | annual | 103,677,922.00 | 103,677,922.00 | 830,418,000.00 | 1,093,908,000.00 | 8,106,078,000.00 | 9,236,587,000.00 | 5,437,732,000.00 | 8,106,078,000.00 | 44,338,000.00 | 8,187,017,000.00 | 8,419,237,000.00 | 8,464,620,000.00 | 277,603,000.00 | 8,187,017,000.00 | 99,380,000.00 | 7,487,150,000.00 | 212,768,000.00 | 103,678,000.00 | 103,678,000.00 | 2,622,846,000.00 | 291,984,000.00 | 874,000.00 | 10,741,000.00 | 874,000.00 | 13,228,000.00 | 267,141,000.00 | 34,921,000.00 | 232,220,000.00 | 10,741,000.00 | 2,330,862,000.00 | 911,000.00 | 826,767,000.00 | 9,417,000.00 | 817,350,000.00 | 413,000.00 | 52,797,000.00 | 1,360,205,000.00 | 357,037,000.00 | 10,204,000.00 | 66,903,000.00 | 926,061,000.00 | 11,087,466,000.00 | 3,318,872,000.00 | 233,224,000.00 | 224,971,000.00 | 0.00 | 2,250,000.00 | 57,833,000.00 | 21,544,000.00 | 34,039,000.00 | 23,794,000.00 | 0.00 | 0.00 | 6,877,000.00 | 80,939,000.00 | 3,828,000.00 | 77,111,000.00 | 2,948,237,000.00 | -613,033,000.00 | 3,561,270,000.00 | 221,549,000.00 | 2,726,688,000.00 | 1,808,674,000.00 | 1,110,960,000.00 | 420,087,000.00 | 0.00 | 7,768,594,000.00 | 705,218,000.00 | 425,849,000.00 | 705,014,000.00 | 1,239,422,000.00 | 0.00 | 148,024,000.00 | 569,617,000.00 | 82,253,000.00 | 439,528,000.00 | 109,875,000.00 | 10,804,000.00 | 3,927,500,000.00 | -146,737,000.00 | 4,074,237,000.00 | 1,350,130,000.00 | 1,130,978,000.00 | 219,152,000.00 | 83,596,000.00 | 135,556,000.00 |
| 2021-03-31T00:00:00 | annual | 103,146,672.00 | 103,146,672.00 | 1,061,175,000.00 | 1,218,995,000.00 | 7,999,638,000.00 | 9,270,056,000.00 | 5,615,638,000.00 | 7,999,638,000.00 | 31,473,000.00 | 8,082,534,000.00 | 8,408,573,000.00 | 8,279,094,000.00 | 196,560,000.00 | 8,082,534,000.00 | 98,376,000.00 | 7,372,284,000.00 | 147,573,000.00 | 103,147,000.00 | 103,147,000.00 | 2,488,764,000.00 | 452,406,000.00 | 1,000.00 | 24,975,000.00 | 1,009,000.00 | 82,091,000.00 | 344,330,000.00 | 18,291,000.00 | 326,039,000.00 | 24,975,000.00 | 2,036,358,000.00 | 509,000.00 | 874,665,000.00 | 13,182,000.00 | 861,483,000.00 | 1,067,000.00 | 86,608,000.00 | 915,499,000.00 | 141,814,000.00 | 11,175,000.00 | 20,263,000.00 | 742,247,000.00 | 10,767,858,000.00 | 3,115,862,000.00 | 106,669,000.00 | 106,669,000.00 | 0.00 | 0.00 | 640,921,000.00 | 0.00 | 640,921,000.00 | 0.00 | 0.00 | 0.00 | 6,893,000.00 | 82,896,000.00 | 5,785,000.00 | 77,111,000.00 | 2,278,234,000.00 | -502,365,000.00 | 2,780,599,000.00 | 23,949,000.00 | 2,254,285,000.00 | 1,489,715,000.00 | 1,122,799,000.00 | 144,136,000.00 | 0.00 | 7,651,996,000.00 | 401,988,000.00 | 828,869,000.00 | 401,988,000.00 | 989,274,000.00 | 0.00 | 143,561,000.00 | 326,467,000.00 | 33,391,000.00 | 485,855,000.00 | 1,554,000.00 | 14,271,000.00 | 4,638,203,000.00 | -87,435,000.00 | 4,725,638,000.00 | 777,837,000.00 | 651,490,000.00 | 126,347,000.00 | 23,965,000.00 | 102,382,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,955,000.00 | 134,291,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 146,000.00 | 146,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -27,794,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: BLISSGVS Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Repayment Of Debt | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Long Term Debt Issuance | Long Term Debt Payments | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Stock Based Compensation | Provisionand Write Offof Assets | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 1,241,193,000.00 | -243,842,000.00 | 154,884,000.00 | 23,140,000.00 | -283,293,000.00 | 235,906,000.00 | 0.00 | 250,069,000.00 | -1,501,000.00 | -12,662,000.00 | -208,930,000.00 | 355,000.00 | -61,001,000.00 | -53,949,000.00 | -53,949,000.00 | 23,140,000.00 | 23,140,000.00 | -88,958,000.00 | -88,958,000.00 | -243,842,000.00 | 154,884,000.00 | -1,328,218,000.00 | 0.00 | 50,084,000.00 | 0.00 | -1,101,042,000.00 | 51,060,000.00 | -1,152,102,000.00 | -277,260,000.00 | 6,033,000.00 | -283,293,000.00 | 0.00 | 1,524,486,000.00 | -348,512,000.00 | 30,416,000.00 | 141,491,000.00 | 334,486,000.00 | -251,003,000.00 | -224,218,000.00 | 29,660,000.00 | -53,673,000.00 | 38,157,000.00 | 147,595,000.00 | 263,798,000.00 | 1,227,000.00 | 262,571,000.00 | 11,146,000.00 | 0.00 | -221,653,000.00 | -2,859,000.00 | 1,460,681,000.00 |
| 2023-03-31T00:00:00 | annual | -594,855,000.00 | -538,953,000.00 | 400,221,000.00 | 20,415,000.00 | -937,990,000.00 | 250,069,000.00 | 0.00 | 219,871,000.00 | 13,957,000.00 | 16,241,000.00 | -249,385,000.00 | 0.00 | -62,969,000.00 | -54,372,000.00 | -54,372,000.00 | 20,415,000.00 | 20,415,000.00 | -138,732,000.00 | -138,732,000.00 | -538,953,000.00 | 400,221,000.00 | -77,509,000.00 | 775,808,000.00 | 132,334,000.00 | 5,000.00 | 721,230,000.00 | 798,303,000.00 | -77,073,000.00 | -931,078,000.00 | 6,912,000.00 | -937,990,000.00 | 0.00 | 343,135,000.00 | -445,551,000.00 | -851,191,000.00 | -29,473,000.00 | -245,220,000.00 | -63,160,000.00 | 150,032,000.00 | -663,370,000.00 | -37,592,000.00 | 39,043,000.00 | 207,234,000.00 | 186,733,000.00 | 1,606,000.00 | 185,127,000.00 | 8,467,000.00 | -5,000.00 | 96,190,000.00 | -3,651,000.00 | 1,060,716,000.00 |
| 2022-03-31T00:00:00 | annual | 614,775,000.00 | -263,612,000.00 | 107,555,000.00 | 22,844,000.00 | -740,031,000.00 | 219,871,000.00 | 0.00 | 131,345,000.00 | -99,228,000.00 | 187,754,000.00 | -237,301,000.00 | 0.00 | -29,624,000.00 | -53,265,000.00 | -53,265,000.00 | 22,844,000.00 | 22,844,000.00 | -156,057,000.00 | -156,057,000.00 | -263,612,000.00 | 107,555,000.00 | -929,751,000.00 | -236,949,000.00 | 58,858,000.00 | 0.00 | -259,257,000.00 | 0.00 | -259,257,000.00 | -729,352,000.00 | 10,679,000.00 | -740,031,000.00 | 0.00 | 1,354,806,000.00 | -339,431,000.00 | 733,725,000.00 | -55,906,000.00 | -315,791,000.00 | 183,443,000.00 | -290,968,000.00 | 1,212,947,000.00 | -40,760,000.00 | 57,077,000.00 | 59,541,000.00 | 173,308,000.00 | 0.00 | 173,308,000.00 | 10,766,000.00 | 0.00 | -38,813,000.00 | -1,376,000.00 | 1,277,598,000.00 |
| 2021-03-31T00:00:00 | annual | 548,452,000.00 | -163,418,000.00 | 96,650,000.00 | 0.00 | -91,242,000.00 | 131,345,000.00 | 0.00 | 153,395,000.00 | 16,146,000.00 | -38,196,000.00 | -207,980,000.00 | -55,495,000.00 | -63,197,000.00 | -55,495,000.00 | -55,495,000.00 | 0.00 | 0.00 | -66,768,000.00 | -66,768,000.00 | -163,418,000.00 | 96,650,000.00 | -469,910,000.00 | -436,889,000.00 | 53,869,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -87,036,000.00 | 4,206,000.00 | -91,242,000.00 | 0.00 | 639,694,000.00 | -285,628,000.00 | -578,862,000.00 | -98,072,000.00 | -69,509,000.00 | -146,762,000.00 | -268,011,000.00 | 3,492,000.00 | -40,647,000.00 | 98,376,000.00 | 24,079,000.00 | 172,297,000.00 | 0.00 | 172,297,000.00 | 8,379,000.00 | 0.00 | 166,464,000.00 | 308,000.00 | 1,041,270,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 528,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -125,528,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 23,663,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -603,149,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -15,000.00 | 0.00 | 0.00 | 0.00 |
NSE: BLISSGVS Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -11.69 | 0.00 | 187.53 | -38.71 | -38.71 | 75.45 | 26.38 | 382.12 | 148.81 | 122.43 | 5.37 | 5.56 | 11.79 | 102.48 | 75.45 | 631.15 | 1.65 | 10.61 | 10.43 | 0.00 | 0.00 | 75.45 | 75.45 | 0.00 | 75.45 | -6.12 | 81.58 | 81.58 | 35.29 | 116.87 | 4.81 | -39.42 | -0.29 | 39.71 | 5.37 | 0.86 | 5.56 | 11.79 | 134.76 | 249.03 | 52.83 | 26.38 | 26.38 | 33.73 | 43.09 | 34.68 | 8.41 | 1.65 | 383.79 | 382.12 | 765.91 | 765.91 |
| 2023-03-31T00:00:00 | annual | -0.48 | 0.00 | 129.71 | -1.72 | -1.72 | 70.86 | 18.67 | 401.32 | 127.99 | 109.32 | 3.76 | 3.24 | 7.50 | 72.10 | 70.86 | 646.70 | 1.90 | 10.55 | 10.38 | 0.00 | 0.00 | 70.86 | 70.86 | 0.00 | 70.86 | -5.88 | 76.73 | 76.73 | 29.34 | 106.07 | 2.15 | -1.72 | -0.37 | 2.08 | 3.76 | 0.50 | 3.24 | 7.50 | 100.73 | 245.37 | 71.44 | 18.67 | 18.67 | 21.79 | 49.44 | 42.17 | 7.28 | 1.90 | 346.10 | 401.32 | 747.43 | 747.43 |
| 2022-03-31T00:00:00 | annual | -27.15 | 0.00 | 164.94 | -90.51 | -90.51 | 15.04 | 17.33 | 390.98 | 74.43 | 57.09 | 4.84 | 2.93 | 8.82 | 78.40 | 15.04 | 619.78 | 1.56 | 10.52 | 10.33 | 0.00 | 0.00 | 15.04 | 15.04 | 0.00 | 15.04 | -8.09 | 23.13 | 23.13 | 31.04 | 54.17 | 2.40 | -90.66 | 73.53 | 17.13 | 4.84 | 1.05 | 2.93 | 8.82 | 118.14 | 228.80 | 67.44 | 17.33 | 17.33 | 22.00 | 53.78 | 45.18 | 8.60 | 1.56 | 346.95 | 390.98 | 737.93 | 737.93 |
| 2021-03-31T00:00:00 | annual | -0.46 | 0.00 | 128.97 | -1.58 | -1.58 | 68.49 | 17.23 | 329.72 | 127.39 | 110.16 | 2.34 | 6.03 | 9.58 | 69.61 | 68.49 | 477.69 | 0.86 | 10.55 | 10.31 | 0.00 | 0.00 | 68.49 | 68.49 | 0.00 | 68.49 | -5.48 | 73.97 | 73.97 | 30.16 | 104.13 | 2.76 | -1.58 | 0.03 | 1.55 | 2.34 | 1.21 | 6.03 | 9.58 | 91.00 | 147.97 | 31.93 | 17.23 | 17.23 | 10.40 | 27.92 | 20.95 | 6.97 | 0.86 | 238.97 | 329.72 | 568.69 | 568.69 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
5.96
P/E
26.719799
P/B
1.656025
Dividend Yield
0.31%
Market Cap
1,680.04 Cr.
Face Value
96.164
Book Value
96.164
ROE
7.93%
EBITDA Growth
145.13 Cr.
Debt/Equity
8.986
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of blissgvs?
The market capitalization of Bliss GVS Pharma Limited is ₹1,680 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Bliss GVS Pharma Limited?
The PE and PB ratios of Bliss GVS Pharma Limited are Not Available and 1.656025 respectively as of 05 Feb 2025.
What is the 52 Week High of Bliss GVS Pharma Limited?
The 52-week high of Bliss GVS Pharma Limited is ₹179.8 as of 05 Feb 2025.
What is the 52 Week Low of Bliss GVS Pharma Limited?
The 52-week low of Bliss GVS Pharma Limited is ₹92.15 as of 05 Feb 2025.
What are the earnings per share (EPS) for Bliss GVS Pharma Limited?
The Earnings Per Share (EPS) of Bliss GVS Pharma Limited is ₹5.96 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Bliss GVS Pharma Limited?
The Return on Equity (ROE) of Bliss GVS Pharma Limited is 7.93% as per the most recent financial year data. Explore more on Fincept.